{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:32:20Z","timestamp":1769074340611,"version":"3.49.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006088","name":"National Center for Emerging and Zoonotic Infectious Diseases","doi-asserted-by":"publisher","award":["Contract HHSD2002015M88158B; Task order 75D30118F0"],"award-info":[{"award-number":["Contract HHSD2002015M88158B; Task order 75D30118F0"]}],"id":[{"id":"10.13039\/100006088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Each year, over 450\u2009000 Lyme disease diagnoses are estimated to occur in the United States, and current preventive measures have been insufficient to stem the rising incidence. An effective human Lyme disease vaccine could be a powerful intervention for population-level impact. In advance of new Lyme disease vaccines coming to market, this study explored barriers to acceptability and motivations for the uptake of a new Lyme disease vaccine. Researchers conducted 9 online focus groups among consumers who may potentially benefit from the vaccine and 30 in-depth interviews among clinician groups who may provide the vaccine. All participants were recruited from three US regions of high Lyme disease incidence. Researchers found that participants shared common motivators to either recommend (clinicians) or accept (consumers) a Lyme disease vaccine, largely driven by perceived benefits of the vaccine, the lack of current effective preventive measures and a greater peace of mind. The concern about the challenges associated with diagnosing and treating Lyme disease is a primary motivator for clinicians to recommend the vaccine, while the concern about getting Lyme disease is a primary motivator for consumers to desire the vaccine.<\/jats:p>","DOI":"10.1093\/her\/cyab032","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:13:22Z","timestamp":1629141202000},"page":"494-504","source":"Crossref","is-referenced-by-count":6,"title":["Understanding consumer and clinician perceptions of a potential Lyme disease vaccine"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-1966","authenticated-orcid":false,"given":"Roshni","family":"Devchand","sequence":"first","affiliation":[{"name":"Hager Sharp, 1030 15th Street NW, Washington, DC 20005, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Koehler","sequence":"additional","affiliation":[{"name":"Hager Sharp, 1030 15th Street NW, Washington, DC 20005, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hook","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), 3156 Rampart Road, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace E","family":"Marx","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), 3156 Rampart Road, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holley","family":"Hooks","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), 3156 Rampart Road, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), 3156 Rampart Road, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Hinckley","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), 3156 Rampart Road, Fort Collins, CO 80521, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"2022022111095201600_R1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital signs: trends in reported vectorborne disease cases\u2014United States and territories, 2004\u20132016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022022111095201600_R2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022022111095201600_R3","article-title":"Lyme Disease Transmission","author":"Centers for Disease Control and Prevention"},{"key":"2022022111095201600_R4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2022022111095201600_R5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.idc.2015.02.005","article-title":"Laboratory diagnosis of Lyme disease: advances and challenges","volume":"29","author":"Marques","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"2022022111095201600_R6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1212\/WNL.0000000000011151","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease","volume":"96","author":"Lantos","year":"2021","journal-title":"Neurology"},{"key":"2022022111095201600_R7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term assessment of post-treatment symptoms in patients with culture-confirmed early Lyme disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022022111095201600_R8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2007.12.011","article-title":"Chronic Lyme disease: a review","volume":"22","author":"Marques","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"2022022111095201600_R9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1473-3099(11)70034-2","article-title":"Antiscience and ethical concerns associated with advocacy of Lyme disease","volume":"11","author":"Auwaerter","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2022022111095201600_R10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jme\/tjv237","article-title":"County-scale distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the continental United States","volume":"53","author":"Eisen","year":"2016","journal-title":"J Med Entomol"},{"key":"2022022111095201600_R11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/infdis\/jiv775","article-title":"Effectiveness of residential acaricides to prevent Lyme and other tick-borne diseases in humans","volume":"214","author":"Hinckley","year":"2016","journal-title":"J Infect Dis"},{"key":"2022022111095201600_R12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2020.101605","article-title":"Experiences with tick exposure, Lyme disease, and use of personal prevention methods for tick bites among members of the U.S. population, 2013\u20132015","volume":"12","author":"Nawrocki","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"2022022111095201600_R13","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"Recommendations for the use of Lyme disease vaccine","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"2022022111095201600_R14","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0264-410X(00)00520-X","article-title":"The prevention of Lyme disease with vaccine","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"key":"2022022111095201600_R15","doi-asserted-by":"crossref","first-page":"s247","DOI":"10.1093\/cid\/ciq115","article-title":"The Lyme disease vaccine\u2014a public health perspective","volume":"52","author":"Shen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022022111095201600_R16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-0009.2012.00663.x","article-title":"The rise and fall of the lyme disease vaccines: a cautionary tale for risk interventions in American medicine and public health","volume":"90","author":"Aronowitz","year":"2012","journal-title":"Milbank Q"},{"key":"2022022111095201600_R17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/art.24418","article-title":"HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination","volume":"60","author":"Ball","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022022111095201600_R18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(01)00500-X","article-title":"Adverse event reports following vaccination for Lyme disease: December 1998\u2013July 2000","volume":"20","author":"Lathrop","year":"2002","journal-title":"Vaccine"},{"key":"2022022111095201600_R19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"2022022111095201600_R20","doi-asserted-by":"crossref","first-page":"s271","DOI":"10.1093\/cid\/ciq119","article-title":"Correcting a public health fiasco: the need for a new vaccine against Lyme disease","volume":"52","author":"Plotkin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022022111095201600_R21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMp1607146","article-title":"Need for a new Lyme disease vaccine","volume":"375","author":"Plotkin","year":"2016","journal-title":"N Engl J Med"},{"key":"2022022111095201600_R22","volume-title":"Valneva"},{"key":"2022022111095201600_R23","volume-title":"Valneva","author":"Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15"},{"key":"2022022111095201600_R24","article-title":"Can a new Lyme disease vaccine overcome a history of distrust and failure?","author":"Flaherty","year":"2019","journal-title":"STAT"},{"key":"2022022111095201600_R25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/infdis\/jiy627","article-title":"Anti-OspA DNA-encoded monoclonal antibody prevents transmission of spirochetes in tick challenge providing sterilizing immunity in mice","volume":"219","author":"Wang","year":"2019","journal-title":"J Infect Dis"},{"key":"2022022111095201600_R26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/infdis\/jiw151","article-title":"Pre-exposure prophylaxis with OspA-specific human monoclonal antibodies protects mice against tick transmission of Lyme disease spirochetes","volume":"214","author":"Wang","year":"2016","journal-title":"J Infect Dis"},{"key":"2022022111095201600_R27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jiph.2016.02.011","article-title":"Susceptibility, likelihood to be diagnosed, worry and fear for contracting Lyme disease","volume":"10","author":"Fogel","year":"2017","journal-title":"J Infect Public Health"},{"key":"2022022111095201600_R28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2019.07.008","article-title":"Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas","volume":"10","author":"Niesobecki","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"2022022111095201600_R29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2051013616629881","article-title":"Intentions to receive a potentially available Lyme disease vaccine in an urban sample","volume":"4","author":"Fogel","year":"2016","journal-title":"Ther Adv Vaccines"},{"key":"2022022111095201600_R30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/160940690600500107","article-title":"Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development","volume":"5","author":"Fereday","year":"2006","journal-title":"Int J Qual Methods"},{"key":"2022022111095201600_R31","volume-title":"Dedoose Mixed Methods and Qualitative Research Software","author":"SocioCultural Research Consultants","year":"2018"},{"key":"2022022111095201600_R32","doi-asserted-by":"crossref","DOI":"10.4135\/9781483384436","volume-title":"Applied Thematic Analysis","author":"Guest","year":"2012"},{"key":"2022022111095201600_R33","volume-title":"Qualitative Data Analysis: An Methods Sourcebook","author":"Miles","year":"2013","edition":"3rd edn"},{"key":"2022022111095201600_R34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"2022022111095201600_R35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"2022022111095201600_R36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/sextrans-2015-052088","article-title":"Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey","volume":"92","author":"Gerend","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2022022111095201600_R37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.vaccine.2016.01.023","article-title":"Provider communication and HPV vaccination: the impact of recommendation quality","volume":"34","author":"Gilkey","year":"2016","journal-title":"Vaccine"},{"key":"2022022111095201600_R38","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.4161\/hv.25823","article-title":"Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines","volume":"9","author":"Gargano","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"2022022111095201600_R39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2105\/AJPH.2012.301189","article-title":"Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males","volume":"103","author":"Reiter","year":"2013","journal-title":"Am J Public Health"},{"key":"2022022111095201600_R40","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1016\/j.vaccine.2020.08.043","article-title":"Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?","volume":"38","author":"Reiter","year":"2020","journal-title":"Vaccine"},{"key":"2022022111095201600_R41","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/vbz.2007.0221","article-title":"Knowledge, attitudes, and behaviors regarding Lyme disease prevention among Connecticut residents, 1999\u20132004","volume":"8","author":"Gould","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2022022111095201600_R42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.amepre.2003.10.010","article-title":"Risk perceptions regarding ticks and Lyme disease: a national survey","volume":"26","author":"Herrington","year":"2004","journal-title":"Am J Prev Med"},{"key":"2022022111095201600_R43","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2105\/AJPH.87.12.2035","article-title":"Predisposing factors for individuals\u2019 Lyme disease prevention practices: Connecticut, Maine, and Montana","volume":"87","author":"Herrington","year":"1997","journal-title":"Am J Public Health"},{"key":"2022022111095201600_R44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1745-7599.2004.tb00368.x","article-title":"Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk population","volume":"16","author":"McKenna","year":"2004","journal-title":"J Am Acad Nurse Pract"},{"key":"2022022111095201600_R45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0749-3797(18)30173-9","article-title":"Determinants of tick-avoidance behaviors in an endemic area for Lyme disease","volume":"13","author":"Shadick","year":"1997","journal-title":"Am J Prev Med"},{"key":"2022022111095201600_R46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2017.11.021","article-title":"U.S. pregnant women\u2019s knowledge and attitudes about behavioral strategies and vaccines to prevent Zika acquisition","volume":"36","author":"Fraiz","year":"2018","journal-title":"Vaccine"},{"key":"2022022111095201600_R47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.vaccine.2016.12.050","article-title":"Zika virus knowledge, attitudes, and vaccine interest among university students","volume":"35","author":"Painter","year":"2017","journal-title":"Vaccine"},{"key":"2022022111095201600_R48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24926\/iip.v3i2.257","article-title":"The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine","volume":"3","author":"Coe","year":"2012","journal-title":"Innov Pharm"},{"key":"2022022111095201600_R49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.puhe.2013.12.004","article-title":"Health Belief Model applied to non-compliance with HPV vaccine among female university students","volume":"128","author":"Donadiki","year":"2014","journal-title":"Public Health"},{"key":"2022022111095201600_R50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/00333549111260S215","article-title":"Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model","volume":"126","author":"Smith","year":"2011","journal-title":"Public Health Rep"},{"key":"2022022111095201600_R51","volume-title":"Theory at A Glance: A Guide for Health Promotion Practice","author":"National Cancer Institute","year":"2005","edition":"2nd edn"},{"key":"2022022111095201600_R52","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.109-5526","article-title":"Facts not enough to change minds about health myths","volume":"189","author":"Collier","year":"2017","journal-title":"CMAJ"}],"container-title":["Health Education Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/her\/article-pdf\/36\/5\/494\/42566091\/cyab032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/her\/article-pdf\/36\/5\/494\/42566091\/cyab032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T12:34:26Z","timestamp":1699360466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/her\/article\/36\/5\/494\/6371272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,16]]},"published-print":{"date-parts":[[2022,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/her\/cyab032","relation":{},"ISSN":["0268-1153","1465-3648"],"issn-type":[{"value":"0268-1153","type":"print"},{"value":"1465-3648","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,9,16]]}}}